These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2505711)

  • 21. The effect of haemodialysis on the pharmacokinetics of perindoprilat after long-term perindopril.
    Guérin A; Resplandy G; Marchais S; Taillard F; London G
    Eur J Clin Pharmacol; 1993; 44(2):183-7. PubMed ID: 8453964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers.
    Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Santoso ID; Arland JA; Setiawati A; Lian LY
    Arzneimittelforschung; 2011; 61(4):234-8. PubMed ID: 21650082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the dose-effect relationship of perindopril in the treatment of arterial hypertension].
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():43-50. PubMed ID: 2505712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modeling of the relation between plasma concentration of the active metabolite of perindopril and inhibition of the activity of plasma converting enzyme in healthy volunteers].
    Bellissant E; Chau NP; Thuillez C; Giudicelli JF
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1285-9. PubMed ID: 2175584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2 mg to young and elderly patients with mild-to-moderate hypertension.
    Arner P; Wade A; Engfeldt P; Mouren M; Stepniewski JP; Sultan E; Bryce T; Lenfant B
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S44-9. PubMed ID: 7527101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Todd PA; Fitton A
    Drugs; 1991 Jul; 42(1):90-114. PubMed ID: 1718688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of perindopril and its metabolites in healthy volunteers.
    Devissaguet JP; Ammoury N; Devissaguet M; Perret L
    Fundam Clin Pharmacol; 1990; 4(2):175-89. PubMed ID: 2351367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects.
    Abdel-Haq B; Magagna A; Favilla S; Salvetti A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S33-6. PubMed ID: 1725198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G; Lederle RM; Scholze J; Stumpe KO
    Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
    Fliser D; Rett K; Hübinger A; Ritz E
    Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence study.
    Jain DS; Subbaiah G; Sanyal M; Pande UC; Shrivastav P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):92-100. PubMed ID: 16709467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of perindopril on hypertension, serum angiotensin-I-converting enzyme activity and urine level of N-acetyl-beta-D-glucosaminidase].
    Wang Z; Li Y; Zhou Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):233-6. PubMed ID: 9868122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perindopril (Coversyl)--a new ACE inhibitor. Perindopril--a review of its pharmacokinetics and clinical pharmacology.
    Reid JL; Macfadyen RJ; Lees KR
    S Afr Med J; 1991 Oct; Suppl():1-5. PubMed ID: 1925812
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
    Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
    Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemodynamic effects of perindopril in essential hypertension.
    Asmar RG; Pannier B; Laurent ST; Benetos A; Daou J; Safar M
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():35-43; discussion 44. PubMed ID: 2283652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and acceptability of perindopril.
    Brown CL
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():51-5; discussion 55-6. PubMed ID: 2283654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.